Major Depression
Studies seek better understanding and treatment of depression
Connecting the dots between two molecules whose levels are decreased in depression and increased by current antidepressants could yield new therapies, researchers say.
Psychology & Psychiatry
Aug 14, 2012 |
not rated yet |
0
Study finds how stress, depression can shrink the brain
Major depression or chronic stress can cause the loss of brain volume, a condition that contributes to both emotional and cognitive impairment. Now a team of researchers led by Yale scientists has discovered ...
Psychology & Psychiatry
Aug 12, 2012 |
4.8 / 5 (6) |
3
|
Yoga proves to reduce depression in pregnant women, boost maternal bonding
It's no secret that pregnancy hormones can dampen moods, but for some expectant moms, it's much worse: 1 in 5 experience major depression.
Health
Aug 08, 2012 |
not rated yet |
0
Creatine aids women in outmuscling major depression
Women battling stubborn major depression may have a surprising new ally in their fightthe muscle-building dietary supplement creatine.
Psychology & Psychiatry
Aug 06, 2012 |
not rated yet |
0
|
Brain signal ID's responders to fast-acting antidepressant
(Medical Xpress) -- Scientists have discovered a biological marker that may help to identify which depressed patients will respond to an experimental, rapid-acting antidepressant. The brain signal, detectable ...
Neuroscience
Aug 06, 2012 |
5 / 5 (1) |
0
|
Depression triples between ages 12 and 15 in girls in U.S.
(HealthDay) -- An average of 12.0 percent of girls aged 12 to 17 years have experienced a major depressive episode (MDE) in the past year, with the rates tripling for girls between the ages of 12 and 15, according ...
Psychology & Psychiatry
Jul 31, 2012 |
5 / 5 (1) |
0
A fresh look at mental illness: Researcher points toward a new way to classify disorders
Ask Assistant Professor of Psychology Joshua Buckholtz to explain his research into mental disorders, and hell likely start with a question thats got more to do with basic medicine: When is the ...
Psychology & Psychiatry
Jul 31, 2012 |
5 / 5 (2) |
8
New research confirms efficacy of transcranial magnetic stimulation for depression
In one of the first studies to look at transcranial magnetic stimulation (TMS) in real-world clinical practice settings, researchers at Butler Hospital, along with colleagues across the U.S., confirmed that ...
Psychology & Psychiatry
Jul 26, 2012 |
4 / 5 (2) |
0
|
Depression a global problem: It's not just Westerners who get the blues
(Medical Xpress) -- Depression and anxiety are found in every society in the world, debunking old theories that only Westerners get depressed.
Psychology & Psychiatry
Jul 23, 2012 |
not rated yet |
0
Researchers link two biological risk factors for schizophrenia
(Medical Xpress) -- Johns Hopkins researchers say they have discovered a cause-and-effect relationship between two well-established biological risk factors for schizophrenia previously believed to be independent of one another.
Psychology & Psychiatry
Jul 17, 2012 |
5 / 5 (3) |
0
|
Scientists identify potential target for treating anhedonia - major symptom of depression
Stanford University School of Medicine scientists have laid bare a novel molecular mechanism responsible for the most important symptom of major depression: anhedonia, the loss of the ability to experience pleasure. While ...
Medical research
Jul 11, 2012 |
4.3 / 5 (6) |
6
|
Report: Too little mental health care for seniors (Update)
(AP) Getting older does not just mean a risk for physical ailments like heart disease and creaky knees: A new report finds as many as 1 in 5 American seniors has a mental health or substance abuse problem.
Psychology & Psychiatry
Jul 10, 2012 |
not rated yet |
0
Hormone curbs depressive-like symptoms in stressed mice
A hormone with anti-diabetic properties also reduces depression-like symptoms in mice, researchers from the School of Medicine at the UT Health Science Center San Antonio reported today.
Medical research
Jul 09, 2012 |
not rated yet |
0
|
Medicare coverage gap associated with reductions in antidepressant use in study
The Medicare Part D coverage gap was associated with reduced use of antidepressants in a study of beneficiaries 65 years or older with depression, according to a report by Archives of General Psychiatry.
Psychology & Psychiatry
Jul 02, 2012 |
not rated yet |
0
GlaxoSmithKline to pay $3 billion for health fraud
(AP) GlaxoSmithKline LLC will pay $3 billion and plead guilty to promoting two popular drugs for unapproved uses and to failing to disclose important safety information on a third in the largest health ...
Other
Jul 02, 2012 |
not rated yet |
0
Major depressive disorder (MDD) (also known as recurrent depressive disorder, clinical depression, major depression, unipolar depression, or unipolar disorder) is a mental disorder characterized by an all-encompassing low mood accompanied by low self-esteem, and by loss of interest or pleasure in normally enjoyable activities. This cluster of symptoms (syndrome) was named, described and classified as one of the mood disorders in the 1980 edition of the American Psychiatric Association's diagnostic manual. The term "depression" is ambiguous. It is often used to denote this syndrome but may refer to other mood disorders or to lower mood states lacking clinical significance. Major depressive disorder is a disabling condition that adversely affects a person's family, work or school life, sleeping and eating habits, and general health. In the United States, around 3.4% of people with major depression commit suicide, and up to 60% of people who commit suicide had depression or another mood disorder.
The diagnosis of major depressive disorder is based on the patient's self-reported experiences, behavior reported by relatives or friends, and a mental status examination. There is no laboratory test for major depression, although physicians generally request tests for physical conditions that may cause similar symptoms. If depressive disorder is not detected in the early stages it may result in a slow recovery and affect or worsen the person's physical health. Standardized screening tools such as Major Depression Inventory can be used to detect major depressive disorder. The most common time of onset is between the ages of 20 and 30 years, with a later peak between 30 and 40 years.
Typically, patients are treated with antidepressant medication and, in many cases, also receive psychotherapy or counseling, although the effectiveness of medication for mild or moderate cases is questionable. Hospitalization may be necessary in cases with associated self-neglect or a significant risk of harm to self or others. A minority are treated with electroconvulsive therapy (ECT). The course of the disorder varies widely, from one episode lasting weeks to a lifelong disorder with recurrent major depressive episodes. Depressed individuals have shorter life expectancies than those without depression, in part because of greater susceptibility to medical illnesses and suicide. It is unclear whether or not medications affect the risk of suicide. Current and former patients may be stigmatized.
The understanding of the nature and causes of depression has evolved over the centuries, though this understanding is incomplete and has left many aspects of depression as the subject of discussion and research. Proposed causes include psychological, psycho-social, hereditary, evolutionary and biological factors. Certain types of long-term drug use can both cause and worsen depressive symptoms. Psychological treatments are based on theories of personality, interpersonal communication, and learning. Most biological theories focus on the monoamine chemicals serotonin, norepinephrine and dopamine, which are naturally present in the brain and assist communication between nerve cells.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
Latest Spotlight News
Engineered cytomegalovirus protects monkeys from HIV equivalent
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
Researchers identify first drug targets in childhood genetic tumor disorder
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
Hormone levels may provide key to understanding psychological disorders in women
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
Going live: Immune cell activation in multiple sclerosis
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
Depression raises diabetics' risk of severe low blood sugar episodes
(Medical Xpress)—Patients with diabetes who are depressed are much more likely to develop episodes of dangerously low blood sugars, or hypoglycemia, than are those who are not depressed, a new study has ...
Controlling mood through the motions of mitochondria
(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...
New immune system discovered
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.
Brain can be trained in compassion, study shows
Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.
Multiple research teams unable to confirm high-profile Alzheimer's study
Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science.
Motion quotient: IQ predicted by ability to filter motion (w/ video)
A brief visual task can predict IQ, according to a new study. This surprisingly simple exercise measures the brain's unconscious ability to filter out visual movement. The study shows that individuals whose ...